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Introduction: Extracranial carotid artery aneurysm (CCA), although uncommon, represents a challenge to treatment
strategy. The purpose of this study was to analyze the treatment evolution and clinical outcome of all patients with CCA
over a two decade period.
Methods: Clinical data of all patients diagnosed with CCA who underwent interventions from 1984 to 2004 were
reviewed. Patients were divided into two groups. Group I (1985-1994) and group II (1995-2004) were compared with
regards to clinical presentation, treatment modality, and clinical outcome.
Results: A total of 42 cases of CCA were found during the study period (group I, n22; group II, n20). Pulsatile neck
mass was the most common presenting symptom (n39, 93%), followed by neurological symptoms (n6, 14%). Twenty
two (52%) were atherosclerotic aneurysms, fifteen (36%) false aneurysms, and five (12%) posttraumatic aneurysms. Both
groups shared similar comorbidities and demographic profiles. All patients in group I underwent operative interventions,
which included 12 resection with interposition bypass grafting (55%), six resection with patch angioplasty (27%), and
four carotid ligation (18%). In group II, five patients underwent resection with interposition placement (25%) and one
carotid ligation (5%). The remaining 14 patients underwent endovascular interventions (70%) which included seven
stent-graft exclusions, six carotid stenting with coil exclusions, and one endovascular occlusion. Hospital length of stay
was significantly shorter in group II than group I (3.5 vs. 9.4 days, p<0.01). The incidence of cranial nerve injury in
group I and II were 14% vs. 5% (p<0.04), respectively. The 30-day mortality/major stroke rates in group I and II were
14% vs. 5% (p< 0.04), respectively. During the follow-up period (0.8months-20 years; mean, 4.6 years), 16 patients died,
largely due to cardiac etiologies (n11, 69%).
Conclusions: Treatment modality of CCA has largely evolved from operative to endovascular intervention at our
institution. Treatment benefits of endovascular modality include shorter convalescent and less procedural-related
complications. This evolution reflects the improvement of endovascular devices and increased utility of endovascular
applications. ( J Vasc Surg 2006;43:493-6.)INTRODUCTION
Aneurysm of the carotid artery aneurysm is an un-
common clinical disease which can occur as the result of
atherosclerotic degeneration, fibromuscular dysplasia, or
traumatic injury. Infrequently, this can also occur as a
complication following a carotid endarterectomy (CEA)
procedure. Because of the risk of aneurysm rupture as well
as the neurological sequalae caused by cerebral atheroem-
bolism, surgical intervention is recommended for a carotid
artery aneurysm (CCA) in order to minimize potential
complications.
A variety of operative techniques have been described
in the treatment of CCA. Sir Astley Cooper reported suc-
cessful treatment of CAA by proximal carotid artery liga-
tion in 1808.1 Subsequently, Dimtza performed first suc-
cessful resection and re-establish the continuity of carotid
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have adapted the surgical technique of aneurysm resection
with either interposition grafting or patch angioplasty as the
operative treatment of choice. Despite this well-recognized
treatment technique, operative repair of CCA often repre-
sents a significant challenge to surgeons particularly in the
presence of extensive inflammation in the surrounding
tissues caused by the aneurysm. Moreover, the internal
carotid artery dissection for distal control can pose added
technical challenges when a CCA extends well above the
carotid bifurcation.
Recent advances in endovascular therapy have resulted
in various minimally-invasive treatment modalities in arte-
rial aneurysmal diseases. Numerous clinical studies have
documented the efficacy and safety of utilizing endovascu-
lar techniques including stent-graft exclusion or coil embo-
lization in the management of arterial aneurysms.3-5 We
have also witnessed an increased utilization of endovascular
modalities in the management of arterial aneurysms, in-
cluding the CCA, in our clinical practice. The increased
treatment options of CCA, which include both open and
endovascular interventions prompted our interest to review
our experience in the treatment of this disease. In this
article, we report our experience in the management of
CCA over the last two decades. Specifically, we described
the changing trend of our treatment strategies and analyzed
493
JOURNAL OF VASCULAR SURGERY
March 2006494 Zhou et althe clinical outcome in patients following either open or
endovascular interventions.
MATERIALS AND METHODS
From September 1985 to October 2004, all patients
who underwent operative repairs for arterial aneurysms (n
7,234) were identified by current procedural terminology
(CPT) codes at the Baylor College of Medicine-affiliated
hospitals, which included the Michael E. DeBakey VA
Medical Center, the Ben Taub General Hospital, and the
Methodist Hospital. Among these patients, 42 patients
(0.6%) underwent operative repair of extracranial carotid
artery aneurysm (CCA) which formed the basis of our
patient cohort. In addition to demographic information,
data were obtained on patient’s relevant co-morbidities,
preoperative imaging studies, treatment indication, thera-
peutic modality, and clinical outcome. Particular attention
was paid to the treatment modality with regards to opera-
tive or endovascular approach. Long-term outcome was
assessed by means of duplex ultrasound and clinic visit
records. For the purpose of comparison, patients were
divided into two groups based on the treatment period.
Group I consisted of patients treated during the first 10
years of the study period, while group II included those
treated the latter 10 years. Analysis was made with regards
to the treatment modality and clinical outcome between
the two groups.
Statistical analyses were performed by using the pooled
Student t test and uncorrected Pearson chi-square test. A
P value less than .05 was considered to be statistically
significant. These calculations were performed using the
Statistical Package of Social Sciences for Windows (SPSS
Inc., Chicago, IL). P values of 0.05 were considered
statistically significant.
RESULTS
Demographic data
During the study period, a total of 42 cases of CCA
repair were performed. Among them, 22 patients under-
went operative repair from 1985 to 1994 (group I) while 20
patients underwent either open or endovascular interventions
for CCA from 1995 to 2004 (group II). In group I, 86% of
the patients were male (n19), similar to 85% in group II
(n17). The age range for the entire patient group was 22
to 87 years. The mean age was 54  16 years in group I
versus 58 18 years in group II. Demographic variables of
the two groups are listed in Table I, which were similar in
terms of their associated comorbidities.
Indications for intervention
Underlying etiologies of CCA are listed in table I,
which were categorized as either post-carotid endarterec-
tomy pseudoaneurysm, atherosclerotic aneurysm, or trau-
matic aneurysm. Among our patients, 22 (52%) were ath-
erosclerotic aneurysms, 15 (36%) pseudoaneurysms, and 5
(12%) posttraumatic aneurysms. Presenting symptoms as-
sociated with CCA are also summarized in Table I. Pulsatileneck mass was the most common presenting symptom
(n39, 93%), followed by neurological symptoms (n6,
14%). Specifically, symptoms associated with neurological
deficits included transient ischemic attack (n2), stroke
(n3), and Horner syndrome (n1). There was no differ-
ence in clinical presentations or underlying etiologies be-
tween the two groups.
Types of interventions
Treatment strategies are listed in Table II. Briefly, all
patients in group I underwent operative repair, which in-
cluded 12 resection with interposition bypass grafting
(55%), six resection with patch angioplasty (27%), and four
carotid ligation (18%). In contrast, patients in group II
underwent either open or endovascular treatment. Among
them, five patients who were treated resection and interpo-
sition graft placement (25%), one received carotid ligation
(5%) and the remaining 14 patients were treated with
endovascular methods (70%), which included stent-graft
exclusions (n7, 35%), carotid stenting with coil exclu-
sions (n6, 30%), and endovascular balloon occlusion
Table I. Patient demographics and clinical characteristics
Group I,
N22
[n (%)]
Group II,
N20
[n (%)]
P
value
Patient characteristics
Age (mean, years) 54  16 58  18 NS
Sex (Male) 19 (86%) 17 (20%) NS
Comorbidities
Coronary artery disease 16 (73%) 15 (75%) NS
COPD 5 (23%) 7 (35%) NS
Hypertension 18 (82%) 17 (85%) NS
Diabetes 3 (14%) 2 (10%) NS
Chronic renal insufficiency 2 (9%) 2 (10%) NS
Etiologies
Atherosclerotic degeneration 12 (55%) 10 (50%) NS
Pseudoaneurysm 8 (36%) 7 (35%) NS
Post-traumatic aneurysm 2 (9%) 3 (15%) NS
Presenting symptoms
Pulsatile neck mass 20 (91%) 19 (95%) NS
TIA 1 (5%) 1 (5%) NS
Stroke 1 (5%) 2 (10%) NS
Horner’s syndrome 1 (5%) 0 NS
Table II. Treatment strategies
Group I
n (%)
Group II
n (%)
Operative repair
Resection and interposition grafts 12 (55%) 5 (25%)
Resection and patch angioplasty 6 (27%) 0
Carotid ligation 4 (18%) 1 (5%)
Endovascular repair
Stent graft exclusion 0 7 (35%)
Stent placement with coil exclusion 0 6 (30%)
Endovascular balloon exclusion 0 1 (5%)
Total 22 (100%) 20 (100%)(n1, 5%). In group II, All patients received life-long
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terventions received an additional six weeks of clopedigrol
(75 mg per day).
Treatment outcome
Clinical outcomes are summarized in Table III. Tech-
nical success was achieved in all patients, including aneu-
rysm resections in surgically treated patients and aneurysm
exclusions in patients treated with endovascular methods.
Three patients (14%) in group I suffered from cranial nerve
injuries following operative repair, in contrast to one pa-
tient (5%) in group II (p 0.04). Wound complications
occurred in two patients (9%) in group I while no patients
in group II developed wound-related complications (p 
0.05). Patients in group II had a significantly shorter
length of hospital stay than group I (3.5  1.2 days vs.
9.4 3.5 days, p0.01). No significant differences in either
30-day stroke rate or perioperative death rate were noted
when comparing the two groups. However, the combined
30-day stroke and death rate was higher in group I (14%)
when compared to group II (5%, p0.04). During a mean
follow-up period of 4.6 year (range, 24 days-20 years), 16
patients died, of which, 11deaths were due to cardiac
etiologies (69%) and procedural-related mortality were
similar between group I and group II (14% and 10%,
respectively).
DISCUSSION
Carotid artery aneurysms, albeit rare, pose treatment
challenges due to formidable surgical complications and
frequently inaccessible locations. With the rapid advance-
ment of endovascular techniques, therapeutic strategy has
shifted toward catheter-based intervention from traditional
open repair. Our series demonstrated the evolution in
treatment strategies of CAA over the last two decades in our
institution and highlights the endovascular therapy as a
feasible and durable alternative with the benefits of shorter
convalescence and less procedure-related complications.
This evolution reflects the improvement of endovascular
devices and increased utility of endovascular applications.
CAA is only encountered in 0.2-5% of all carotid artery
surgeries.6-8 The most common causes of CAA are athero-
sclerotic degeneration, fibromuscular dysplasia, trauma, and
Table III. Clinical outcomes
Group I,
N22
[n (%)]
Group II,
N20
[n (%)] P value
Technical success 22 (100%) 20 (100%) NS
Cranial nerve injury 3 (14%) 1 (5%) 0.04
Wound infection/
complication 2 (9%) 0 0.05
Length of hospital stay (days) 9.4  3.5 3.5  1.2 0.01
30-day stroke rate 1 (5%) 0 NS
Perioperative death rate 2 (9%) 1 (5%) NS
30-day stroke and death rate 3 (14%) 1 (5%) 0.04CEA-related complications. Studies have demonstrated theincidence of CAA ranging from 0.02% to 0.4% among all
trauma patients. Hughes et al identified seven patients with
CAA among 3342 trauma patients over a three-year period
and among 189 patients undergoing MRI screening.9 Of
the 38 cases reported by Pulli et al, 26% were caused by
atherosclerotic degeneration, 16% were due to dysplastic
changes, and 13% were pseudoaneurysms. Their findings
were also confirmed in an earlier report from our institution
by McCollum et al who reviewed 37 extracranial CAA over
21 years and found that 44% were atherosclerotic aneu-
rysms, 51% were pseudoaneurysms, and 5% were due to
trauma.10 Furthermore, another large series of 67 cases
reported by El-Sabrout and Cooley demonstrated that 57%
were resulted from prior CEA and 43% were secondary to
atherosclerosis or trauma.11 Our series of 42 patients dem-
onstrated similar distribution in etiologies of CAA as re-
ported in the literature. 50% of our patients had atheroscle-
rotic aneurysms, 38% had false aneurysms, and 12% were
caused by trauma.
The natural history of CAA is conical growth and thus,
has the potential for rupture, distal embolization, and local
compression. Neurological symptoms are common in this
group of patients. McCollum et al identified 15% of their
patients had neurological symptoms and palpable masses in
all patients.10 In El-Sabrout report, 59% of patients pre-
sented with cervical masses, 43% had neurological symp-
toms, more than 10% had local compression symptoms,
and 3% of patients presented with rupture or impending
rupture.11 Moreau and colleagues also confirmed 74% of
their patients had cerebral ischemic symptoms.12 Similar to
the reports in the literature, 14% of our patients also had
neurological deficits.
The potential severe complications associated with
CAA obligate surgical intervention. A review by Winslow
indicated that nonoperative management had mortality
rate of 71%, while carotid ligation was associated with 28%
mortality.13 El-Sabrout and Cooley reported mortality and
major stroke rate of 9%-12% for surgical reconstruction as
comparing to 50% mortality after ligation. Surgical treat-
ment generally involves five options including aneurysm
clipping, resection and end-to-end anastomosis, resection
with interposition graft, extracranial to intracranial bypass,
and carotid artery ligation. Despite decreased complication
rate after open surgical repair over time, the morbidity is
still significant. Moreau and associates reported only 2.6%
perioperative mortality, yet 26% of all surgically treated
patients had cranial nerve palsy.12 In 2000, Hertzer ad-
dressed extracranial carotid aneurysms in a commentary
and indicated that although rate of stroke is only 4% in his
experience, the incidence of cranial nerve dysfunction ap-
proaching 44%. He further raised the questions on possibly
medical management of symptomatic pseudoaneurysms
due to high mortality and morbidity. Our open surgical
treatment included resection and interposition grafting,
resection and patch angioplasty, and ligation. All three
cranial nerve injuries in our patients occurred during open
surgical repairs. Perioperative mortality and major stroke
rate in the open surgical group between 1985 and 1994was
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patients underwent endovascular interventions.
Endovascular approach offers the advantage of avoid-
ing difficult dissection and eliminating the needs for high
cervical exposure, thus reducing the risk of cranial nerve
injuries and other procedure-related complications. Several
endovascular techniques have been used to treat CAA,
including bare stent with or without transstent coiling,4,5
autogenous vein covered stents,14 endovascular balloon
occlusion,15 and stent-grafts, such as Viabahn® (WL Gore,
Flagstaff, AZ) and Wallgraft® (Boston Scientific, Natick,
MA).16,17 Our group, in 2001, evaluated 5 patients received
endovascular interventions for carotid artery pseudoaneu-
rysms and reported 100% patency rate during an average
8.4 months follow up, ranging from 2 to 21 months.4 Most
endovascular treatments of CAA are derived from experi-
ence of managing traumatic or intracranial pseudoaneu-
rysms. Saatci et al reported using stentgraft treating 25
distal ICA aneurysms and majority of the aneurysm were
post-traumatic.3 They reported no aneurysm recanalization
during their six months to two year follow-up and all initial
symptoms due to mass effect were resolved. Additionally,
Coldwell and colleagues treated 14 patients with traumatic
pseudoaneurysms using primarily Wallstents with addi-
tional Palmaz stent in selected patients.5 During a mean
follow-up of 16 months, no patient had worsening of their
neurological status or complications attributable to the
presence of the Wallstent. Our series demonstrated similar
results. During a mean follow-up period of 4.6 year, eleven
of the 16 deaths were due to cardiac etiologies and contin-
ued aneurysm exclusion was confirmed in all patients.
This review highlights an evolution in the treatment of
CAA at our institution. Patients treated before 1995 were
exclusively repaired with open surgical interventions while
later patients were treated with either surgical or endovas-
cular therapies depending on the individual surgeon’s pref-
erence and the locations of the lesions. The patients with
lesions in distal cervical locations tended to be treated with
endovascular methods. Within the limitations of an obser-
vational data set, our series clearly demonstrates that endo-
vascular intervention is a feasible and durable alternative
with the advantages of less convalescence and procedure-
related complications. Despite isolated reports of compli-
cations related to endovascular intervention,18 it is a safe
and effective therapeutic option in experienced hands.
However, long-term follow-up is warranted.
In conclusion, our experience of treating CAA over the
last two decades reflects the evolution of treatment modal-
ities. Our review demonstrated endovascular intervention as
an effective alternative in treating CAA with less procedure-
related complications and shorter recovery time particular
for patients with prohibitive surgical risks or patients
with distal located aneurysms that preclude safe surgical
approach.
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